Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.

Source:http://linkedlifedata.com/resource/pubmed/id/18341639

Download in:

View as

General Info

PMID
18341639